EUVIMEDEUVIMED entdecken
BeobachtungsstudieVergleichsstudieMultizentrische StudieOpen Access · CC BY-NC 4.0

Comparative Risk for Neuropsychiatric Events in Leukotriene Receptor Antagonist vs. Inhaled Corticosteroid in Children With Asthma: A Nationwide Observational Study With a Complementary Analysis Using Natural Language Processing

Subin Kim, Chang Hoon Han, Junhyuk Chang, Jaehyeong Cho, Kyunguk Jeong, Hamin Kim, Mireu Park, Soo Yeon Kim, Jong Deok Kim, Myung Hyun Sohn, Sooyoung Lee, Rae Woong Park und 2 weitere

Pharmacoepidemiology and Drug Safety · 2025

DOI: 10.1002/pds.70254 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Pharmacoepidemiology and Drug Safety, 2025. Verfasst von Subin Kim und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Systems Informatics, Yonsei University College of Medicine, Seoul, South Korea. Hauptthemen laut MEDLINE: Asthma, Leukotriene Antagonists, Adrenal Cortex Hormones, Anti-Asthmatic Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ministry of Food and Drug Safety, Ministry of Health and Welfare (Ministry of Health, Welfare and Family Affairs), South Korea., National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Leukotriene receptor antagonists (LTRAs) are widely prescribed as controller medications for pediatric asthma. However, there have been increasing concerns about potential neuropsychiatric adverse reactions associated with LTRAs. Findings from observational studies have been inconsistent, and direct comparisons of the risk of neuropsychiatric events (NPEs) between LTRAs and inhaled corticosteroids (ICS) remain limited in the pediatric population.

Methods

A retrospective cohort study was conducted utilizing a nationwide claims database (January 2018–April 2022) and a multicenter electronic health record (EHR) database (January 2006–March 2022) from South Korea. Patients aged 5–18 years diagnosed with asthma before initiating LTRA or ICS were included. The primary outcome was NPEs within 90 days of exposure, defined using two methods: diagnostic code‐based analysis and natural language processing (NLP)‐based analysis using clinical notes. After propensity score stratification, Cox proportional hazards models were used to estimate risks.

Results

The diagnostic code‐based analysis on the claims database included 169 636 LTRA users and 28 845 ICS users. There was no statistically significant difference in the risk of NPEs between LTRA and ICS (calibrated hazard ratios [HRs], 1.14 [95% CI, 0.92–1.42]). In the NLP‐based analysis using EHR database, 1641 LTRA users and 1607 ICS users were included. The results were consistent with those of the diagnostic code‐based analysis (calibrated HR, 1.33 [95% CI, 0.66–2.68]).

Conclusions

LTRA use was not found to be associated with a significantly increased risk of NPEs in children with asthma. These findings offer valuable insights to support clinical decision‐making in pediatric asthma treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AsthmaLeukotriene AntagonistsAdrenal Cortex HormonesAnti-Asthmatic AgentsMental DisordersHumansChildMaleFemaleRetrospective StudiesChild, PreschoolAdolescentRepublic of KoreaNatural Language ProcessingElectronic Health RecordsAdministration, InhalationDatabases, Factual

Stichwörter der Autor:innen

drug‐related side effects and adverse reactionsleukotriene antagonistsnatural language processing

Substanzen

Leukotriene AntagonistsAdrenal Cortex HormonesAnti-Asthmatic Agents

Autor:innen und Institutionen

  • Department of Biomedical Systems Informatics, Yonsei University College of Medicine, Seoul, South Korea.
  • Institute for Innovation in Digital Healthcare, Yonsei University, Seoul, South Korea.
  • Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, South Korea.
  • Department of Research, Keimyung University Dongsan Medical Center, Daegu, South Korea.
  • Department of Pediatrics, Ajou University School of Medicine, Suwon, South Korea.
  • Department of Pediatrics, Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.

ORCID-Profile: Seng Chan You

Förderung

  • Ministry of Food and Drug Safety
  • Ministry of Health and Welfare (Ministry of Health, Welfare and Family Affairs), South Korea.
  • National Research Foundation of Korea
  • Ministry of Health and Welfare

Zitieren

APA

Kim, S., Han, C. H., Chang, J., Cho, J., Jeong, K., Kim, H., Park, M., Kim, S. Y., Kim, J. D., Sohn, M. H., Lee, S., Park, R. W., You, S. C., & Kim, K. W. (2025). Comparative Risk for Neuropsychiatric Events in Leukotriene Receptor Antagonist vs. Inhaled Corticosteroid in Children With Asthma: A Nationwide Observational Study With a Complementary Analysis Using Natural Language Processing. Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.70254

Vancouver

Kim S, Han CH, Chang J, Cho J, Jeong K, Kim H, et al. Comparative Risk for Neuropsychiatric Events in Leukotriene Receptor Antagonist vs. Inhaled Corticosteroid in Children With Asthma: A Nationwide Observational Study With a Complementary Analysis Using Natural Language Processing. Pharmacoepidemiology and Drug Safety. 2025. doi:10.1002/pds.70254

BibTeX
@article{Kim2025,
  author = {Kim, Subin and Han, Chang Hoon and Chang, Junhyuk and Cho, Jaehyeong and Jeong, Kyunguk and Kim, Hamin and Park, Mireu and Kim, Soo Yeon and Kim, Jong Deok and Sohn, Myung Hyun and Lee, Sooyoung and Park, Rae Woong and You, Seng Chan and Kim, Kyung Won},
  title = {Comparative Risk for Neuropsychiatric Events in Leukotriene Receptor Antagonist vs. Inhaled Corticosteroid in Children With Asthma: A Nationwide Observational Study With a Complementary Analysis Using Natural Language Processing},
  journal = {Pharmacoepidemiology and Drug Safety},
  year = {2025},
  doi = {10.1002/pds.70254}
}
Kostenlos starten →